EGFR-AS1 was found to be overexpressed in diverse cancers, including lung cancer, cervical cancer, glioma, bladder cancer, kidney cancer, head and neck cancer, gastric cancer, colorectal cancer, liver cancer, and uterine cancer. This evidence concerns the gene EGFR and urinary bladder carcinoma.